17,20S(OH)<sub>2</sub>pD Can Prevent the Development of Skin Fibrosis in the Bleomycin-Induced Scleroderma Mouse Model
Systemic sclerosis (SSc; scleroderma) is a chronic fibrotic disease involving TGF-β1. Low serum vitamin D (vit D) correlates with the degree of fibrosis and expression of TGF-β1. This study was designed to determine whether the noncalcemic vit D analog, 17,20S(OH)<sub>2</sub>pD, suppress...
Main Authors: | Monica L. Brown Lobbins, Imara-Safi O. Scott, Andrzej T. Slominski, Karen A. Hasty, Sicheng Zhang, Duane D. Miller, Wei Li, Tae-Kang Kim, Zorica Janjetovic, Tejesh S. Patel, Linda K. Myers, Arnold E. Postlethwaite |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-08-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/1422-0067/22/16/8926 |
Similar Items
-
Modulation by 17,20S(OH)<sub>2</sub>pD of Fibrosis-Related Mediators in Dermal Fibroblast Lines from Healthy Donors and from Patients with Systemic Sclerosis
by: Monica L. Brown Lobbins, et al.
Published: (2021-12-01) -
Vitamin A Derivative Etretinate Improves Bleomycin-induced Scleroderma
by: Takaharu Ikeda, et al.
Published: (2005-01-01) -
A critical role of AREG for bleomycin-induced skin fibrosis
by: Mary Yinghua Zhang, et al.
Published: (2021-02-01) -
The Effect of Dexamethasone on Bleomycin-Induced Lung Fibrosis in the Mouse Model of Systemic Sclerosis
by: Salar PashangZadeh, et al.
Published: (2018-10-01) -
Evaluation of renal damage in a bleomycin-induced murine model of systemic sclerosis
by: Dulce Pérez-Figueroa, et al.
Published: (2023-07-01)